Literature DB >> 2155427

Abnormal structure and expression of p53 gene in human hepatocellular carcinoma.

B Bressac1, K M Galvin, T J Liang, K J Isselbacher, J R Wands, M Ozturk.   

Abstract

There is little information regarding the molecular mechanisms of hepatocarcinogenesis. We studied the p53 gene at the DNA, RNA, and protein level in seven human hepatocellular carcinoma (HCC)-derived cell lines; six of seven showed p53 abnormalities. By Southern blotting, the p53 gene was found to be partially deleted in Hep 3B and rearranged in SK-HEP-1 cells. Transcripts of the p53 gene were undetectable in Hep 3B as well as in FOCUS cells that had no apparent deletion or rearrangement of the p53 gene. Immunoprecipitation after [35S]methionine labeling of HCC cells demonstrated that p53 protein was absent in Hep 3B and FOCUS and reduced in concentration in PLC/PRF/5 cells. p53 synthesized by Mahlavu cells showed a slower migration on SDS/polyacrylamide gels suggesting it was an abnormal protein. In Huh7 cells, p53 protein had a prolonged half-life leading to its accumulation in the nuclei; increased levels of p53 protein were also found by immunoblotting. The p53 gene and its expression appeared to be unaltered in the hepatoblastoma-derived Hep G2 cell line. We found that the loss of p53 expression did not occur as a late in vitro event in the FOCUS cell line because p53 protein was also nondetectable at an early passage. We conclude that the loss of p53 expression or the presence of abnormal forms of the protein are frequently associated with HCC cell lines. These observations suggest that alterations in p53 may be important events in the transformation of hepatocytes to the malignant phenotype.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155427      PMCID: PMC53607          DOI: 10.1073/pnas.87.5.1973

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Characterization of the human p53 gene.

Authors:  P Lamb; L Crawford
Journal:  Mol Cell Biol       Date:  1986-05       Impact factor: 4.272

2.  Hepatitis B virus integration site in hepatocellular carcinoma at chromosome 17;18 translocation.

Authors:  O Hino; T B Shows; C E Rogler
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

3.  Chromosomal site of hepatitis B virus (HBV) integration in a human hepatocellular carcinoma-derived cell line.

Authors:  D Simon; D B Searls; Y Cao; K Sun; B B Knowles
Journal:  Cytogenet Cell Genet       Date:  1985

4.  Molecular cloning of an oncogene from a human hepatocellular carcinoma.

Authors:  T Ochiya; A Fujiyama; S Fukushige; I Hatada; K Matsubara
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

5.  Identification and characterization of a Mr 50,000 adrenal protein in human hepatocellular carcinoma.

Authors:  M Ozturk; P Motté; H Takahashi; M Frohlich; B Wilson; L Hill; B Bressac; J R Wands
Journal:  Cancer Res       Date:  1989-12-01       Impact factor: 12.701

6.  Expression of p53 in human leukemia and lymphoma.

Authors:  M Prokocimer; M Shaklai; H B Bassat; D Wolf; N Goldfinger; V Rotter
Journal:  Blood       Date:  1986-07       Impact factor: 22.113

Review 7.  The hepatitis B virus.

Authors:  P Tiollais; C Pourcel; A Dejean
Journal:  Nature       Date:  1985 Oct 10-16       Impact factor: 49.962

8.  Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation.

Authors:  L F Parada; H Land; R A Weinberg; D Wolf; V Rotter
Journal:  Nature       Date:  1984 Dec 13-19       Impact factor: 49.962

9.  Precise epitope mapping of the murine transformation-associated protein, p53.

Authors:  A Wade-Evans; J R Jenkins
Journal:  EMBO J       Date:  1985-03       Impact factor: 11.598

10.  Human p53 cellular tumor antigen: cDNA sequence and expression in COS cells.

Authors:  R Zakut-Houri; B Bienz-Tadmor; D Givol; M Oren
Journal:  EMBO J       Date:  1985-05       Impact factor: 11.598

View more
  105 in total

1.  p53-Independent and -dependent requirements for E1B-55K in adenovirus type 5 replication.

Authors:  J N Harada; A J Berk
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  The point mutation of p53 gene exon7 in hepatocellular carcinoma from Anhui Province, a non HCC prevalent area in China.

Authors:  Hu Liu; Yuan Wang; Qing Zhou; Shu-Yu Gui; Xu Li
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

3.  p53 functions as a cell cycle control protein in osteosarcomas.

Authors:  L Diller; J Kassel; C E Nelson; M A Gryka; G Litwak; M Gebhardt; B Bressac; M Ozturk; S J Baker; B Vogelstein
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

4.  The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytes.

Authors:  Jörn M Schattenberg; Marcus A Wörns; Tim Zimmermann; You-Wen He; Peter R Galle; Marcus Schuchmann
Journal:  Free Radic Biol Med       Date:  2012-03-08       Impact factor: 7.376

5.  The major histocompatibility complex class I antigen-binding protein p88 is the product of the calnexin gene.

Authors:  K Galvin; S Krishna; F Ponchel; M Frohlich; D E Cummings; R Carlson; J R Wands; K J Isselbacher; S Pillai; M Ozturk
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

Review 6.  How do persistent infections with hepatitis C virus cause liver cancer?

Authors:  Jonathan K Mitchell; Stanley M Lemon; David R McGivern
Journal:  Curr Opin Virol       Date:  2015-09-29       Impact factor: 7.090

7.  Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma.

Authors:  K Ashida; Y Kishimoto; K Nakamoto; K Wada; G Shiota; Y Hirooka; Y Kamisaki; T Itoh; H Kawasaki
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

8.  p53 mediates the negative regulation of MDM2 by orphan receptor TR3.

Authors:  Bi-xing Zhao; Hang-zi Chen; Na-zi Lei; Gui-deng Li; Wen-xiu Zhao; Yan-yan Zhan; Bo Liu; Sheng-cai Lin; Qiao Wu
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

9.  Chaga mushroom (Inonotus obliquus) induces G0/G1 arrest and apoptosis in human hepatoma HepG2 cells.

Authors:  Myung-Ja Youn; Jin-Kyung Kim; Seong-Yeol Park; Yunha Kim; Se-Jin Kim; Jin-Seok Lee; Kyu-Yun Chai; Hye-Jung Kim; Ming-Xun Cui; Hong-Seob So; Ki-Young Kim; Raekil Park
Journal:  World J Gastroenterol       Date:  2008-01-28       Impact factor: 5.742

10.  Comparative analysis of p53 and c-myc expression and cell proliferation in human hepatocellular carcinomas--an enhanced immunohistochemical approach.

Authors:  M Saegusa; Y Takano; H Kishimoto; G Wakabayashi; K Nohga; M Okudaira
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.